Exploring innovative regulatory pathways: a US perspective
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Presentation
- By: LIBERTI, Lawrence (CIRS, Holland, United States)
- Co-author(s): Lawrence Liberti: CIRS, Holland, United States
Pharmaceutical innovation results from the efficient partnership between drug developers, regulators, payers and patients among others stakeholders. A regulatory agency, with the support of its legislature, can stimulate and support innovation through the active application of various elements of regulatory science. In the US, programmes have.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.